UNSPSC 51351630: Estrone benzoate

This classification denotes an estrogen with the molecular formula C25H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O636LYL5W8, chemically known as estra-1,3,5(10)-trien-17-one, 3-(benzoyloxy)-, but more generally known as estrone benzoate, which bears US NIH Compound Identifier 16963. European Medicines Agency schedules estrone benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07251MIG. Most nations, for tariff purposes, schedule estrone benzoate under HS 29372300.

SMILES: C[C@]12CC[C@@H]3C4CCC(CC4CC[C@H]3[C@@H]1CCC2=O)OC(=O)C5CCCCC5.

UNSPSC 51351630 Estrone benzoate, a Commodity code, addresses the procurement of this synthetic estrogen compound by state and local governments, though recent state and local solicitation activity under this code is absent from available records. The code nominally covers a pharmaceutical or chemical intermediate used in hormone replacement therapies, veterinary medicine, and research applications. Without recent opportunities in the state and local procurement record, no issuing-body mix or geographic concentration is evident.

No recent state and local contract opportunities appear under this code. Procurement professionals should verify whether state and local buyers in this space are using alternative UNSPSC classifications or alternative procurement channels such as cooperative purchasing vehicles, group purchasing organizations, or direct-award schedules that may not surface in standard opportunity databases.